Linagliptin Works in Diabetic Kidney Disease

ADA 2011 — SAN DIEGO — Type 2 diabetes patients with impaired renal function saw significant drops in HbA1c after treatment with linagliptin (Tradjenta) when compared with placebo, researchers said here.


< Back to Listings